» Articles » PMID: 27060448

Differential Expression Between Human Dermal Papilla Cells from Balding and Non-Balding Scalps Reveals New Candidate Genes for Androgenetic Alopecia

Overview
Publisher Elsevier
Specialty Dermatology
Date 2016 Apr 10
PMID 27060448
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Androgenetic alopecia (AGA) is a common heritable and androgen-dependent hair loss condition in men. Twelve genetic risk loci are known to date, but it is unclear which genes at these loci are relevant for AGA. Dermal papilla cells (DPCs) located in the hair bulb are the main site of androgen activity in the hair follicle. Widely used monolayer-cultured primary DPCs in hair-related studies often lack dermal papilla characteristics. In contrast, immortalized DPCs have high resemblance to intact dermal papilla. We derived immortalized human DPC lines from balding (BAB) and non-balding (BAN) scalp. Both BAB and BAN retained high proportions of dermal papilla signature gene and versican protein expression. We performed expression analysis of BAB and BAN and annotated AGA risk loci with differentially expressed genes. We found evidence for AR but not EDA2R as the candidate gene at the AGA risk locus on chromosome X. Further, our data suggest TWIST1 (twist family basic helix-loop-helix transcription factor 1) and SSPN (sarcospan) to be the functionally relevant AGA genes at the 7p21.1 and 12p12.1 risk loci, respectively. Down-regulated genes in BAB compared to BAN were highly enriched for vasculature-related genes, suggesting that deficiency of DPC from balding scalps in fostering vascularization around the hair follicle may contribute to the development of AGA.

Citing Articles

Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia.

Xiao Y, Zhang Y, Deng S, Yang X, Yao X Clin Rev Allergy Immunol. 2025; 68(1):22.

PMID: 40024940 DOI: 10.1007/s12016-025-09034-5.


The Pharmacokinetics of Topical Finasteride 0.25% Spray in Chinese Adult Male Volunteers with Androgenic Alopecia: A Phase I Study.

Tai Z, Cui Z, Shi X, Li H, Chai R, Huang Y Adv Ther. 2025; 42(3):1494-1505.

PMID: 39907898 DOI: 10.1007/s12325-025-03106-w.


Quercetin rescues dihydrotestosterone-treated human dermal papilla cells via SHP2/AKT signaling to suppress autophagy and apoptosis.

Guo T, Li W, Zheng W, Lin Y, Wen S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39718610 DOI: 10.1007/s00210-024-03742-z.


Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives.

Li Y, Dong T, Wan S, Xiong R, Jin S, Dai Y Comput Struct Biotechnol J. 2024; 23:2623-2636.

PMID: 39021583 PMC: 11253216. DOI: 10.1016/j.csbj.2024.06.026.


Topical Minoxidil Rejuvenates Hair Follicles from Men with Androgenetic Alopecia in Vivo.

Zeltzer A, Keren A, Paus R, Gilhar A Acta Derm Venereol. 2024; 104:adv24213.

PMID: 38860623 PMC: 11181920. DOI: 10.2340/actadv.v104.24213.